3.35 USD
↘ 0.09 (2.76%)AT CLOSE (11:59 AM EDT)
Pluri Inc. Common Stock
PLURNASDAQ • USD
3.35
↗ 0.00 (0.03%)
POST MARKET (AS OF 04:15 PM EDT)
Post Market
AS OF 04:15 PM EDT
3.35
↗ 0.00 (0.03%)
Market: CLOSED
Open?$3.39
High?$3.52
Low?$3.20
Prev. Close?$3.44
Volume?9.2K
Avg. Volume?6.4K
VWAP?$3.39
Rel. Volume?1.45x
Bid / Ask
Bid?$2.25 × 500
Ask?$3.74 × 100
Spread?$1.49
Midpoint?$3.00
Valuation & Ratios
Market Cap?36.1M
Shares Out?10.8M
Float?7.0M
Float %?69.2%
P/E Ratio?N/A
P/B Ratio?-2.52
EPS?-$2.43
Dividend?0.00%
Ex-Dividend?N/A
Technical Outlook
Loading...
Fundamental Outlook
Loading...
Short Interest
Loading...
Financial Health
Current Ratio?0.42Weak
Quick Ratio?0.42Weak
Cash Ratio?0.14Low
Debt/Equity?-1.94Low
ValuationFAIRLY VALUED
Score67/100
P/E?N/A▾
P/B?-2.52CHEAP▾
P/S?26.96HIGH▾
P/FCF?N/A▾
EV/EBITDA?-2.4CHEAP▾
EV/Sales?44.20HIGH▾
Returns & Efficiency
ROE?182.7%STRONG▾
ROA?-85.4%WEAK▾
Cash Flow & Enterprise
FCF?$-22013000
Enterprise Value?$59.2M
Fundamentals ratios updated end of day
xxx
Related Companies
Loading...
News
Profile
Pluri Inc is a biotechnology company engaged in the research, development, and manufacturing of cell-based products, as well as the commercialization of cell therapeutics and related technologies aimed at delivering solutions across a range of industries, including regenerative medicine, immunotherapy, food tech, CDMO, and AgTech. The company uses its 3D cell expansion technology platform to develop placenta-based cell therapy product candidates (PLX-PAD and PLX-R18) for the treatment of inflammatory, muscle injuries, and hematologic conditions. In addition, it offers CDMO services through PluriCDMO, has launched a novel immunotherapy platform, and is engaged in developing cultivated, cell-cultured coffee and meat.
Employees
142
Market Cap
36.0M
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Website
Listed
1991-10-09
Address
MATAM ADVANCED TECHNOLOGY PARK
HAIFA,
Phone: 972-74-710-7171
HAIFA,
Phone: 972-74-710-7171